Supplementary Material for: Urine Osmolality and Renal Outcome in Patients with Chronic Kidney Disease: Results from the KNOW-CKD
Mi Jung Lee(Yonsei University Health System), Seung Hyeok Han(Yonsei University), Tara I. Chang, Y.H. Kim, Kyu Hun Choi(Yonsei University), Kook‐Hwan Oh(Seoul National University), Tae‐Hyun Yoo(Yonsei University), Ju Hee Lee(East Tennessee State University), Sung Won Lee(Pusan National University Hospital), Jung Tak Park(FIND), S.W. Kim, Choonghyun Ahn, Shin‐Wook Kang(Yonsei University)
Cited by 0
Related Papers
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
|Circulation|2019|1.3k
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716
Characterization of ferroptosis in kidney tubular cell death under diabetic conditions
|Cell Death and Disease|2021|298
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
|The Lancet Respiratory Medicine|2021|225
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
|Nephrology Dialysis Transplantation|2020|189